Stay updated on Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial
Sign up to get notified when there's something new on the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page.

Latest updates to the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdds a new publication citation for the ALLIANCE open-label extension phase (Avihingsanon et al.) and updates the page revision from v3.6.3 to v3.6.4.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision tag updated to v3.6.3, replacing the previous v3.6.2.SummaryDifference0.0%

- Check37 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2, indicating a new page build. The change represents an updated deployment of the page rather than modification to the study data.SummaryDifference0.0%

- Check51 days agoChange DetectedEnrollment status updated to 'No longer looking for participants,' indicating recruitment is closed. New navigation items and labels (How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment) were added, existing label formatting was adjusted, and the revision tag updated to v3.6.0.SummaryDifference0.2%

- Check58 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, signaling a minor site update. There are no visible changes to the study details or layout.SummaryDifference0.0%

- Check79 days agoChange DetectedNew page revision v3.5.4 was added, replacing the previous v3.5.3. This indicates a routine maintenance update to the page’s revision history rather than a content change.SummaryDifference0.0%

Stay in the know with updates to Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page.